Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Cash from Financing Activities (2019 - 2025)

Historic Cash from Financing Activities for Cresco Labs (CRLBF) over the last 7 years, with Q3 2025 value amounting to -$71.1 million.

  • Cresco Labs' Cash from Financing Activities fell 278538.96% to -$71.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$119.4 million, marking a year-over-year decrease of 682540.85%. This contributed to the annual value of -$71.5 million for FY2024, which is 16564.83% down from last year.
  • According to the latest figures from Q3 2025, Cresco Labs' Cash from Financing Activities is -$71.1 million, which was down 278538.96% from -$42.0 million recorded in Q4 2024.
  • Cresco Labs' Cash from Financing Activities' 5-year high stood at $155.9 million during Q3 2021, with a 5-year trough of -$71.1 million in Q3 2025.
  • For the 5-year period, Cresco Labs' Cash from Financing Activities averaged around $10.4 million, with its median value being -$2.5 million (2024).
  • As far as peak fluctuations go, Cresco Labs' Cash from Financing Activities soared by 105768.97% in 2021, and later crashed by 278538.96% in 2025.
  • Cresco Labs' Cash from Financing Activities (Quarter) stood at -$2.4 million in 2021, then rose by 14.48% to -$2.0 million in 2022, then plummeted by 86.21% to -$3.8 million in 2023, then crashed by 1011.42% to -$42.0 million in 2024, then tumbled by 69.14% to -$71.1 million in 2025.
  • Its Cash from Financing Activities was -$71.1 million in Q3 2025, compared to -$42.0 million in Q4 2024 and -$2.5 million in Q3 2024.